Neptune Wellness Solutions Logo
CA64079L1058
A2N6DW
NEPT

Neptune Wellness Solutions

Loading quotes...

Forecast

Buy
  1
Hold
  0
Sell
  0

  • Neptune sets price for secondary offering at $27.50 per share

    Neptune set the price for a secondary offering of 9,841,395 Class A shares at $27.50 per share; the shares are being sold by selling shareholders and the company will not receive any proceeds. Neptune intends to repurchase and retire 984,140 shares from the underwriters at $26.40 per share; closing is expected on Friday and is subject to customary conditions and the successful completion of the offering. The underwriters have been granted a 30-day option to purchase up to 1,476,209 additional shares at the offering price. Morgan Stanley is lead left bookrunner; the S-1 was declared effective by the SEC on May 13, 2026. The stock is trading at $27.94, market capitalization is $3.95 billion, analysts expect a return to profitability, and InvestingPro currently views the stock as overvalued. » More on de.investing.com


  • Neptune announces secondary placement of 8.36 million shares by selling shareholders

    Certain selling shareholders of Neptune intend to publicly place 8,355,615 class A common shares; the syndicate banks have a 30-day option on up to 1,253,342 additional shares. Neptune will also repurchase 835,561 shares from the syndicate banks at the same price and cancel them, subject to customary closing conditions and a successful offering. Morgan Stanley is lead left bookrunner, J.P. Morgan and Goldman Sachs are active bookrunners; a Form S-1 registration statement has been filed with the SEC but is not yet effective. The announcement follows a 22% rise in the stock last week; Neptune is due to report results in two days, and analysts expect a return to profitability. » More on de.investing.com


  • Neptune targets IPO in New York after strong growth and high margin

    Flood insurer Neptune has filed for an IPO in New York and plans to list under the ticker NP. The company, founded in 2018, reported $119.3m in revenue and $34.6m in net income in 2024, implying roughly a 29% margin; H1 2025 also showed further strong growth. The offering is being led by Morgan Stanley, J.P. Morgan and BofA Securities, with BMO Capital Markets, Goldman Sachs and Evercore ISI as additional syndicate banks. » More on de.investing.com

Historical dividends Dividends

All dividend metrics All metrics
In 2008, Neptune Wellness Solutions has already paid €0.19 in dividends. The last payout was in August 2008.

Financials

In the last year, Neptune Wellness Solutions had revenue of €48.4m and net profit of -€75.17m
(EUR) 2023
YoY
Revenue 48.4m 9.82%
Gross profit -4.51m 58.63%
Net profit -75.17m 11.21%
EBITDA -58m 19.61%

Fundamentals

Metric Value
Market capitalization
€762.89k
Number of shares
4.29m
52-week high/low
€0.18 - €0.18
Dividends No
Beta
2.19
P/E ratio
-2.77
PEG ratio
-0.02
P/B ratio
4.91
P/S ratio
0.00

Company profile

Neptune Wellness Solutions Inc. operates as an integrated health and wellness company. It builds a portfolio of lifestyle brands and consumer packaged goods products under the Biodroga Neutraceuticals, Forest Remedies, Ocean Remedies, Neptune Wellness, Mood Ring, PanHash, Sprout, Nosh, and NurturMe brands. The company offers turnkey product development and supply chain solutions to business customers in various health and wellness verticals, such as legal cannabis and hemp, nutraceuticals, and white label consumer packaged goods. It is also involved in the extraction, purification, formulation, and manufacturing of health and wellness products, such as omega-3 and hemp-derived products under various delivery forms, such as soft gels, liquids, capsules, vape pens, sprays, topicals, sachets, tinctures, concentrates, edibles, and beverages, as well as hand sanitizers, non-contact thermometers, and gloves. In addition, the company offers Maxsimil, an omega-3 fatty acid delivery technology that uses enzymes that mimic the natural human digestive system to predigest omega-3 fatty acids. It has a collaboration agreement with International Flavors & Fragrances Inc. to co-develop hemp-derived CBD products for the mass retail, and health and wellness markets. The company was incorporated in 1998 and is headquartered in Laval, Canada.

Name
Neptune Wellness Solutions
CEO
Lisa H. Gainsborg CPA
Headquarters Laval, qc
Canada
Website
Sector
Materials
Industry
Chemicals
IPO
13/08/2007
Employees 50

Ticker symbols

Exchange Symbol
NASDAQ
NEPT
🍪

Parqet  uses cookies. Learn more